Mind Medicine (MNMD)

Company Profile

Mind Medicine Inc., also known as MindMed, is a New York-based psychedelic medicine biotech company that develops psychedelic-inspired medicines known as psychoplastogens and therapies to address addiction and mental illness.

Company profile

Ticker

MNMD, MMCWF, MMDCF

Exchange

NASDAQ

Website

mindmed.co/

CEO

Robert Barrow

Incorporated

British Columbia, Canada

Location

New York

Fiscal year end

Dec 31

Sector

Manufacturing > Medicinal and Botanical Manufacturing

Industry (SIC)

Medicinal Chemicals & Botanical Products

Curaleaf • Jushi • Ascend Wellness • Trulieve Cannabis • Usana Health Sciences • 4Front Ventures • SNDL • Glass House Brands • C21 Investments • Mannatech ...

SEC CIK

0001813814

Corporate docs

Underwriting Agreements

Indentures

Material Contracts & Credit Agreements

Subsidiaries Lists

Subsidiaries

Mind Medicine, Inc. • MindMed Discover GmbH • MindMed Pty Ltd • Healthmode, Inc. ...

MNMD stock data

1M 1Y 5Y

Latest filings (excl ownership)

View all

Company Logo MindMed Investor Presentation August 2023

14 Aug 23

8-K

Entry into a Material Definitive Agreement

MindMed Reports Second Quarter 2023 Financial Results and Business Highlights

3 Aug 23

8-K/A

Submission of Matters to a Vote of Security Holders

25 Jul 23

8-K

Submission of Matters to a Vote of Security Holders

27 Jun 23

8-K

Regulation FD Disclosure

20 Jun 23

DEFA14A

Additional proxy soliciting materials

16 Jun 23

Transcripts

View all

MNMD

Earnings call transcript

2022 Q3

10 Nov 22

MNMD

Earnings call transcript

2022 Q2

12 Aug 22

MNMD

Earnings call transcript

2022 Q1

16 May 22

MNMD

Earnings call transcript

2021 Q4

28 Mar 22

MNMD

Earnings call transcript

2021 Q2

16 Aug 21

Latest ownership filings

View all

Schond L. Greenway

28 Aug 23

144

Notice of proposed sale of securities

28 Aug 23

144

Notice of proposed sale of securities

Financial summary

Financial statements Chart MNMD financial data

Quarter (USD)	Jun 23	Mar 23	Dec 22	Sep 22
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Dec 22	Dec 21
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	116.90 mm	116.90 mm	116.90 mm	116.90 mm	116.90 mm	116.90 mm
Cash burn (monthly)	4.17 mm	(no burn)	9.73 mm	6.74 mm	4.62 mm	4.11 mm
Cash used (since last report)	11.75 mm	n/a	27.41 mm	19.00 mm	13.00 mm	11.58 mm
Cash remaining	105.14 mm	n/a	89.49 mm	97.89 mm	103.89 mm	105.31 mm
Runway (months of cash)	25.2	n/a	9.2	14.5	22.5	25.6

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q2 2023

MNMD institutional ownership history Ownership history

14.7% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	82	84	-2.4%
Opened positions	7	7	–
Closed positions	9	24	-62.5%
Increased positions	12	15	-20.0%
Reduced positions	12	21	-42.9%

13F shares	Current	Prev Q	Change
Total value	13.79 bn	12.23 bn	+12.8%
Total shares	5.85 mm	5.90 mm	-0.9%
Total puts	126.90 k	185.55 k	-31.6%
Total calls	2.12 mm	2.19 mm	-3.4%
Total put/call ratio	0.1	0.1	-29.2%

Largest owners	Shares	Value	Change
CVI Investments	1.97 mm	$0.00	0.0%
Alyeska Investment	796.96 k	$2.85 bn	-23.6%
Vanguard	567.89 k	$2.03 bn	-1.1%
BLK Blackrock	553.31 k	$1.98 bn	+22.4%
Geode Capital Management	371.01 k	$1.32 bn	+9.1%
Busey Wealth Management	244.35 k	$872.32 mm	0.0%
Charles Schwab Investment Management	179.81 k	$641.92 mm	+0.5%
Cresset Asset Management	159.50 k	$569.41 mm	NEW
Two Sigma Investments	157.74 k	$563.15 mm	-6.2%
STT State Street	122.00 k	$435.54 mm	0.0%

Largest transactions	Shares	Bought/sold	Change
Alyeska Investment	796.96 k	-245.68 k	-23.6%
Susquehanna International	0.00	-232.03 k	EXIT
Cresset Asset Management	159.50 k	+159.50 k	NEW
BLK Blackrock	553.31 k	+101.32 k	+22.4%
Cornercap Investment Counsel	56.48 k	+56.48 k	NEW
Group One Trading	50.15 k	+50.15 k	NEW
Millennium Management	46.55 k	+46.55 k	NEW
Geode Capital Management	371.01 k	+30.96 k	+9.1%
BK Bank Of New York Mellon	64.06 k	+29.78 k	+86.9%
Renaissance Technologies	36.52 k	-19.27 k	-34.5%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

MNMD insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
25 Aug 23	Schond L. Greenway	Common Shares	Sell	Dispose S	No	No	3.8	20,000	76.00 k	228,031
27 Jun 23	Schond L. Greenway	Common Shares	Sell	Dispose S	No	No	3.21	3,941	12.65 k	248,031
27 Jun 23	Schond L. Greenway	Common Shares	Sell	Dispose S	No	No	3.19	7,694	24.54 k	251,972
27 Jun 23	Dan Karlin	Common Shares	Sell	Dispose S	No	No	3.21	2,963	9.51 k	378,722
27 Jun 23	Dan Karlin	Common Shares	Sell	Dispose S	No	No	3.19	3,820	12.19 k	381,685
27 Jun 23	Robert Barrow	Common Shares	Sell	Dispose S	No	No	3.21	8,416	27.02 k	623,457
27 Jun 23	Robert Barrow	Common Shares	Sell	Dispose S	No	No	3.19	7,086	22.60 k	631,873